hodgkin's lymphoma is it curable?
442823
Hodgkin lymphoma is considered one of the most treatable cancers, with more than 90 percent of patients surviving more than five years. Most patients with Hodgkin lymphoma live long and healthy lives following successful treatment.
1346773
According to the ACS, the five-year survival rate for stage 4 Hodgkin's lymphoma is about 65 percent. The five-year survival rate for people with stage 4 NHL varies depending on the subtype of NHL and other factors. Ask your doctor for more information about your diagnosis, treatment options, and long-term outlook.
203623
They relate to the number of people who are still alive 1 year or 5 years after their diagnosis of cancer. Some people live much longer than 5 years. The 1, 5 and 10 year survival statistics for all stages of Hodgkin lymphoma are for relative survival.
691700
More than 50% of elderly DLBCL patients can be expected to be cured by modern immunochemotherapy. The standard chemotherapy partner of rituximab is the CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) regimen.
979996
Few of the known risk factors for Hodgkin lymphoma (HL) can be changed, so it's not possible to prevent most cases of the disease at this time.
500262
Hodgkin lymphoma was named after the doctor who first recognised it. It used to be called Hodgkin's disease. Hodgkin lymphoma has a particular appearance under the microscope and contains cells called Reed-Sternberg cells.
771905
Cyclophosphamide is used alone or in combination with other medications to treat Hodgkin's lymphoma (Hodgkin's disease) and non-Hodgkin's lymphoma (types of cancer that begin in a type of white blood cells that normally fights infection); cutaneous T-cell lymphoma (CTCL, a group of cancers of the immune system that ...
1375031
Signs and symptoms of Hodgkin's lymphoma may include: Painless swelling of lymph nodes in your neck, armpits or groin. Persistent fatigue. Fever.
463278
Sezary syndrome is difficult to cure. Treatment is usually palliative, with the intention of relief of symptoms and improvement in the quality of life.
910206
Chronic lymphocytic leukemia (CLL) can rarely be cured. Still, most people live with the disease for many years. Some people with CLL can live for years without treatment, but over time, most will need to be treated. Most people with CLL are treated on and off for years.
810305
Acute leukemias can often be cured with treatment. Chronic leukemias are unlikely to be cured with treatment, but treatments are often able to control the cancer and manage symptoms. Some people with chronic leukemia may be candidates for stem cell transplantation, which does offer a chance for cure.
190503
Survival. For most types of blood cancer, the proportion of people who live five or more years after diagnosis has increased significantly over the past decade. The 5 year survival rates range from 42% for myeloma to 85% for Hodgkin Lymphoma.
282457
These rates may be affected by the subtype and stage of Hodgkin lymphoma and the age and gender of the patient. The 5-year survival rate for all people with Hodgkin lymphoma is 87%. If the cancer is found in its earliest stages, the 5-year survival rate is 92%.
1297123
ABVD is used to treat Hodgkin lymphoma. It is best to read this information with our general information about chemotherapy and the type of cancer you have. ABVD is named after the initials of the chemotherapy drugs used in the treatment.
640984
Non-Hodgkin lymphoma is usually treated with chemotherapy or radiotherapy, although some people may not need treatment straight away. In a few cases, if the initial cancer is very small and can be removed during a biopsy, no further treatment may be needed.
1193794
Mantle cell lymphoma is not curable with conventional chemoimmunotherapy. Overall, the median survival is approximately 6 to 7 years.
1418
Hodgkin lymphoma most often spreads through the lymph vessels from lymph node to lymph node. Rarely, late in the disease, it can invade the bloodstream and spread to other parts of the body, such as the liver, lungs, and/or bone marrow.